Advisory: Alert incorrectly tagged to Curis Inc withdrawn
12/01/2026 18:18
An alert on Danish drugmaker Curasight A/S CURAS.TE announcing preliminary data from the phase 1 trial for its drug, uTREAT, was inadvertently tagged to U.S.-based Curis Inc CRIS.O, an unrelated entity, and has been withdrawn. There will be no substitute. STORY_NUMBER: nTUA4WDPQN STORY_DATE: January 12, 2026 STORY_TIME: 06:03 PM GMT ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Curis
See all newsBrief: Curis Announces Eleven Active Clinical Sites In TakeAim CLL Study
Curis Q1 operating loss widens as expenses rise
Curis Inc Q4 revenue misses estimates
Advisory: Alert incorrectly tagged to Curis Inc withdrawn
Brief: Curis Announces Closing Of Private Placement Totaling Up To $80.8 Million In Gross Proceeds